HUE056738T2 - Eljárás gyógyszer elleni antitestek, különösen kezelés kapcsán kialakuló gyógyszer elleni antitestek detektálására és/vagy mérésére - Google Patents

Eljárás gyógyszer elleni antitestek, különösen kezelés kapcsán kialakuló gyógyszer elleni antitestek detektálására és/vagy mérésére

Info

Publication number
HUE056738T2
HUE056738T2 HUE15723216A HUE15723216A HUE056738T2 HU E056738 T2 HUE056738 T2 HU E056738T2 HU E15723216 A HUE15723216 A HU E15723216A HU E15723216 A HUE15723216 A HU E15723216A HU E056738 T2 HUE056738 T2 HU E056738T2
Authority
HU
Hungary
Prior art keywords
drug antibodies
detecting
methods
particular treatment
emergent
Prior art date
Application number
HUE15723216A
Other languages
English (en)
Inventor
Veerle Snoeck
Marie-Ange Buyse
Judith Baumeister
Original Assignee
Ablynx Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ablynx Nv filed Critical Ablynx Nv
Publication of HUE056738T2 publication Critical patent/HUE056738T2/hu

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • G01N33/6857Antibody fragments
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
HUE15723216A 2014-05-16 2015-05-13 Eljárás gyógyszer elleni antitestek, különösen kezelés kapcsán kialakuló gyógyszer elleni antitestek detektálására és/vagy mérésére HUE056738T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461994472P 2014-05-16 2014-05-16

Publications (1)

Publication Number Publication Date
HUE056738T2 true HUE056738T2 (hu) 2022-03-28

Family

ID=53189050

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE15723216A HUE056738T2 (hu) 2014-05-16 2015-05-13 Eljárás gyógyszer elleni antitestek, különösen kezelés kapcsán kialakuló gyógyszer elleni antitestek detektálására és/vagy mérésére

Country Status (8)

Country Link
US (2) US11009511B2 (hu)
EP (2) EP3143403B1 (hu)
AU (2) AU2015261467B2 (hu)
CA (1) CA2948945C (hu)
DK (1) DK3143403T3 (hu)
ES (1) ES2900852T3 (hu)
HU (1) HUE056738T2 (hu)
WO (1) WO2015173342A1 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2948945C (en) * 2014-05-16 2023-08-08 Ablynx Nv Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies
MX2019011702A (es) * 2017-03-31 2019-11-01 Ablynx Nv Ensayos de inmunogenicidad mejorados.
WO2024083843A1 (en) 2022-10-18 2024-04-25 Confo Therapeutics N.V. Amino acid sequences directed against the melanocortin 4 receptor and polypeptides comprising the same for the treatment of mc4r-related diseases and disorders

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100081792A1 (en) 2001-06-28 2010-04-01 Smithkline Beecham Corporation Ligand
EP1412390A2 (en) 2001-07-26 2004-04-28 Tanox, Inc. Agents that activate or inhibit toll-like receptor 9
US20060002935A1 (en) 2002-06-28 2006-01-05 Domantis Limited Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
FR2846667B1 (fr) 2002-11-06 2004-12-31 Pasteur Institut Fragments variables d'anticorps de camelides a chaine unique diriges contre le peptide beta-amyloide 1-42 et leurs applications pour le diagnostic et le traitement des maladies neuroagregatives
WO2004041865A2 (en) 2002-11-08 2004-05-21 Ablynx N.V. Stabilized single domain antibodies
CN101412759A (zh) 2003-01-10 2009-04-22 埃博灵克斯股份有限公司 治疗性多肽,其同源物、其片段及其在调节血小板介导的聚集方面的应用
CA2588892A1 (en) 2004-12-02 2006-06-08 Dormantis Limited Anti-il-1r1 single domain antibodies and therapeutic uses
EP1888640B1 (en) 2005-05-18 2012-03-14 Ablynx N.V. Improved nanobodies against tumor necrosis factor-alpha
PL3415535T3 (pl) 2005-05-20 2021-06-14 Ablynx N.V. Ulepszone Nanociała TM do leczenia zaburzeń, w których pośredniczy agregacja
US7989219B2 (en) 2005-05-31 2011-08-02 Canon Kabushiki Kaisha Bispecific capturing molecule
EP1957536A2 (en) 2005-12-01 2008-08-20 Domantis Limited Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1
EP1957537A2 (en) 2005-12-01 2008-08-20 Domantis Limited Competitive domain antibody formats that bind interleukin 1 receptor type 1
FR2894741B1 (fr) 2005-12-08 2009-12-04 Centre Nat Etd Spatiales Chaine de reception par satellite
EP1976991A1 (en) 2006-01-24 2008-10-08 Domantis Limited Fusion proteins that contain natural junctions
WO2008020079A1 (en) 2006-08-18 2008-02-21 Ablynx N.V. Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of deseases and disorders associated with il-6-mediated signalling
WO2009068630A1 (en) 2007-11-27 2009-06-04 Ablynx N.V. Immunoglobulin constructs
DE102008023620A1 (de) 2008-05-15 2009-11-19 Mettler-Toledo (Albstadt) Gmbh Funktionseinheit mit einer aufrufbaren Funktion und Verfahren zu deren Aufruf
US9212226B2 (en) 2008-05-16 2015-12-15 Ablynx N.V. Amino acid sequences directed against CXCR4 and other GPCRs and compounds comprising the same
US20110200525A1 (en) 2008-10-09 2011-08-18 Patz Jr Edward F Vhh antibody fragments for use in the detection and treatment of cancer
WO2010130832A2 (en) 2009-05-15 2010-11-18 Ablynx N.V. Amino acid sequences directed against dickkopf-1 and polypeptides comprising the same for the treatment of diseases and disorders associated with bone loss and/or osteolytic lesions
WO2011003622A1 (en) 2009-07-10 2011-01-13 Ablynx N.V. Method for the production of variable domains
US8306355B2 (en) 2009-07-13 2012-11-06 Sharp Laboratories Of America, Inc. Methods and systems for reducing compression artifacts
KR101721187B1 (ko) * 2009-12-23 2017-03-29 에스바테크 - 어 노바티스 컴파니 엘엘씨 면역원성의 감소 방법
JP2013145769A (ja) 2010-08-04 2013-07-25 Kri Inc 異方性希土類ボンド磁石とその製造方法
WO2012175400A1 (en) 2011-06-23 2012-12-27 Ablynx Nv Serum albumin binding proteins
US20180009888A9 (en) * 2011-06-23 2018-01-11 Ablynx N.V. Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
TW201321405A (zh) 2011-08-17 2013-06-01 Glaxo Group Ltd 經修飾之蛋白質及肽
CA2948945C (en) * 2014-05-16 2023-08-08 Ablynx Nv Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies

Also Published As

Publication number Publication date
AU2015261467A1 (en) 2016-12-01
AU2021201640A1 (en) 2021-04-08
WO2015173342A1 (en) 2015-11-19
EP3143403B1 (en) 2021-10-27
DK3143403T3 (da) 2022-01-17
US11009511B2 (en) 2021-05-18
US20210341490A1 (en) 2021-11-04
ES2900852T3 (es) 2022-03-18
CA2948945C (en) 2023-08-08
AU2015261467B2 (en) 2020-12-17
US20170082637A1 (en) 2017-03-23
CA2948945A1 (en) 2015-11-19
EP3982124A1 (en) 2022-04-13
EP3143403A1 (en) 2017-03-22

Similar Documents

Publication Publication Date Title
IL265396A (en) Methods and compositions for detecting analytes
EP3183560A4 (en) Sensor and System for Measuring a Concentration
GB2549860B (en) Biomolecule measurement system and biomolecule measurement method
GB201612928D0 (en) Position measurement method,own position measurement device, and in-vehicle device
PL3169990T3 (pl) Wykrywanie i pomiar pęknięć w zbiornikach metalurgicznych
PL3218113T3 (pl) Wirówka i sposób rejestracji niewyważeń w wirówce
HK1225759A1 (zh) 用於檢測川崎病的方法及試劑盒
PL3113729T3 (pl) Urządzenie mechanoterapeutyczne i sposób pomiaru
PL3155364T3 (pl) Układ czujnikowy, urządzenie pomiarowe i sposób pomiaru
SG11201702250PA (en) Line measurement device and method
EP3220149A4 (en) Specimen measurement device and specimen measurement method
PT3096784T (pt) Péptidos, dispositivos e métodos para a deteção de anticorpos de anaplasma
IL246642A0 (en) Materials and methods for quantifying pld-1 protein levels
HK1244414A1 (zh) 用於確定肺濕度的設備和方法
SG11201701312TA (en) Method for detecting target molecule, and kit for use in said method
EP3128296A4 (en) Measurement value analysis device and measurement value analysis method
GB201615078D0 (en) Measurement device and method
HK1250778A1 (zh) 分析物檢測及其方法
GB2542762B (en) Measuring device and method
HK1247285A1 (zh) 用於測量樣本中的血清素的方法和系統
GB201517837D0 (en) Measuring device and related method
GB2529063B (en) Detecting device, detecting method and program
EP3147371A4 (en) Novel method for detecting detection object in sample, and detection kit using same
HUE056738T2 (hu) Eljárás gyógyszer elleni antitestek, különösen kezelés kapcsán kialakuló gyógyszer elleni antitestek detektálására és/vagy mérésére
PT2966441T (pt) Sensor e método para deteção de androstenona ou escatol em odor a varrasco